Abstract

BACKGROUND: Chronic kidney disease (CKD) is associated with an increased cardiovascular disease mortality risk. It is, however, less clear at what point in the course from normal kidney function to CKD the association with cardiovascular disease appears. Studying the associations of estimated glomerular filtration rate (eGFR) and albuminuria with biomarkers of (subclinical) cardiac injury in a population without substantial CKD may clarify this issue.

METHODS: We examined the cross-sectional associations of eGFR and urinary albumin excretion (UAE) with high-sensitivity cardiac troponin (hs-cTn) T, hs-cTnI, and N-terminal probrain natriuretic-peptide (NT-proBNP) in 3103 individuals from a population-based diabetes-enriched cohort study.

RESULTS: After adjustment for potential confounders, eGFR and UAE were associated with these biomarkers of cardiac injury, even at levels that do not fulfill the CKD criteria. For example, eGFR 60-= 90 mL . min(-1) . (1.73 m(2))(-1)] was associated with a [ratio (95% CI)] 1.21 (1.17-1.26), 1.14 (1.07-1.20), and 1.19 (1.12-1.27) times higher hscTnT, hs-cTnI, and NT-proBNP, respectively. The association of eGFR with hs-cTnT was statistically significantly stronger than that with hs-cTnI. In addition, UAE 15-

CONCLUSIONS: eGFR and albuminuria were already associated with biomarkers of (subclinical) cardiac injury at levels that do not fulfill the CKD criteria. Although reduced renal elimination may partly underlie the associations of eGFR, these findings support the concept that eGFR and albuminuria are, over their entire range, associated with cardiac injury. (C) 2016 American Association for Clinical Chemistry

Original languageEnglish
Pages (from-to)887-897
Number of pages11
JournalClinical Chemistry
Volume63
Issue number4
DOIs
Publication statusPublished - Apr 2017

Keywords

  • CHRONIC KIDNEY-DISEASE
  • ACUTE MYOCARDIAL-INFARCTION
  • STAGE RENAL-DISEASE
  • TROPONIN-T
  • NATRIURETIC PEPTIDE
  • CYSTATIN C
  • CARDIOVASCULAR-DISEASE
  • DIABETIC-NEPHROPATHY
  • NONDIALYSIS PATIENTS
  • NT-PROBNP

Cite this